Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs

被引:212
作者
Bai, O [1 ]
Chlan-Fourney, J [1 ]
Bowen, R [1 ]
Keegan, D [1 ]
Li, XM [1 ]
机构
[1] Univ Saskatchewan, Neuropsychiat Res Unit, Dept Psychiat, Saskatoon, SK S7N 5EA, Canada
关键词
haloperidol; clozapine; olanzapine; BDNF; hippocampus;
D O I
10.1002/jnr.10440
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Typical and atypical antipsychotic drugs, though both effective, act on different neurotransmitter receptors and are dissimilar in some clinical effects and side effects. The typical antipsychotic drug haloperidol has been shown to cause a decrease in the expression of brain-derived neurotrophic factor (BDNF), which plays an important role in neuronal cell survival, differentiation, and neuronal connectivity. However, it is still unknown whether atypical antipsychotic drugs similarly regulate BDNF expression. We examined the effects of chronic (28 days) administration of typical and atypical antipsychotic drugs on BDNF mRNA expression in the rat hippocampus using in situ hybridization. Quantitative analysis revealed that the typical antipsychotic drug haloperidol (1 mg/kg) down-regulated BDNF mRNA expression in both CA1 (P < 0.05) and dentate gyrus (P < 0.01) regions compared with vehicle control. In contrast, the atypical antipsychotic agents clozapine (10 mg/kg) and olanzapine (2.7 mg/kg) up-regulated BDNF mRNA expression in CA1, CA3, and dentate gyrus regions of the rat hippocampus compared with their respective controls (P < 0.01). These findings demonstrate that the typical and atypical antipsychotic drugs differentially regulate BDNF mRNA expression in rat hippocampus. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 32 条
[1]
Angelucci F, 2000, J NEUROSCI RES, V60, P783, DOI 10.1002/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO
[2]
2-M
[3]
Beasley CM, 1997, J CLIN PSYCHIAT, V58, P7
[4]
DIVALENT ION PERMEABILITY OF AMPA RECEPTOR CHANNELS IS DOMINATED BY THE EDITED FORM OF A SINGLE SUBUNIT [J].
BURNASHEV, N ;
MONYER, H ;
SEEBURG, PH ;
SAKMANN, B .
NEURON, 1992, 8 (01) :189-198
[5]
DIFFERENTIAL-EFFECTS OF MK-801 ON BRAIN-DERIVED NEUROTROPHIC FACTOR MESSENGER-RNA LEVELS IN DIFFERENT REGIONS OF THE RAT-BRAIN [J].
CASTREN, E ;
BERZAGHI, MD ;
LINDHOLM, D ;
THOENEN, H .
EXPERIMENTAL NEUROLOGY, 1993, 122 (02) :244-252
[6]
COFFIN VL, 1989, J PHARMACOL EXP THER, V249, P769
[7]
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses [J].
Durany, N ;
Michel, T ;
Zöchling, R ;
Boissl, KW ;
Cruz-Sánchez, FF ;
Riederer, P ;
Thome, J .
SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) :79-86
[8]
CELL LOSS IN THE HIPPOCAMPUS OF SCHIZOPHRENICS [J].
FALKAI, P ;
BOGERTS, B .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1986, 236 (03) :154-161
[9]
REGULATION OF CORTICAL AND SUBCORTICAL GLUTAMATE-RECEPTOR SUBUNIT EXPRESSION BY ANTIPSYCHOTIC-DRUGS [J].
FITZGERALD, LW ;
DEUTCH, AY ;
GASIC, G ;
HEINEMANN, SF ;
NESTLER, EJ .
JOURNAL OF NEUROSCIENCE, 1995, 15 (03) :2453-2461
[10]
Olanzapine - A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses [J].
Fulton, B ;
Goa, KL .
DRUGS, 1997, 53 (02) :281-298